Entrada Therapeutics (TRDA) Earnings Date & Reports
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
TRDA is expected to report earnings to fall 2.97% to -98 cents per share on November 05
Q3'26
Est.
$-0.98
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.04
Q3'25
Missed
by $0.07
The last earnings report on August 05 showed earnings per share of -100 cents, beating the estimate of -104 cents. With 247.92K shares outstanding, the current market capitalization sits at 197.02M.